Annual Shareholders Equity
$61.67 M
-$16.77 M-21.37%
December 31, 2024
Summary
- As of March 7, 2025, JSPR annual stockholders equity is $61.67 million, with the most recent change of -$16.77 million (-21.37%) on December 31, 2024.
- During the last 3 years, JSPR annual shareholders equity has fallen by -$7.84 million (-11.28%).
- JSPR annual shareholders equity is now -21.37% below its all-time high of $78.44 million, reached on December 31, 2023.
Performance
JSPR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$61.67 M
-$22.01 M-26.30%
December 31, 2024
Summary
- As of March 7, 2025, JSPR quarterly stockholders equity is $61.67 million, with the most recent change of -$22.01 million (-26.30%) on December 31, 2024.
- Over the past year, JSPR quarterly shareholders equity has dropped by -$22.01 million (-26.30%).
- JSPR quarterly shareholders equity is now -50.74% below its all-time high of $125.20 million, reached on March 31, 2023.
Performance
JSPR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
JSPR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.4% | -26.3% |
| 3 y3 years | -11.3% | -34.5% |
| 5 y5 years | +275.6% | -34.5% |
JSPR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.4% | +71.4% | -50.7% | +71.4% |
| 5 y | 5-year | -21.4% | +275.6% | -50.7% | +275.6% |
| alltime | all time | -21.4% | +275.6% | -50.7% | +275.6% |
Jasper Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $61.67 M(-21.4%) | $61.67 M(-26.3%) |
| Sep 2024 | - | $83.68 M(-16.6%) |
| Jun 2024 | - | $100.31 M(-11.4%) |
| Mar 2024 | - | $113.23 M(+44.4%) |
| Dec 2023 | $78.44 M | $78.44 M(-16.7%) |
| Sep 2023 | - | $94.13 M(-14.6%) |
| Jun 2023 | - | $110.20 M(-12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $125.20 M(+247.9%) |
| Dec 2022 | $35.99 M(-48.2%) | $35.99 M(-24.3%) |
| Sep 2022 | - | $47.56 M(-19.1%) |
| Jun 2022 | - | $58.78 M(-13.7%) |
| Mar 2022 | - | $68.11 M(-2.0%) |
| Dec 2021 | $69.52 M(-297.9%) | $69.52 M(-11.6%) |
| Sep 2021 | - | $78.60 M(-323.7%) |
| Dec 2020 | -$35.13 M | -$35.13 M |
FAQ
- What is Jasper Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Jasper Therapeutics?
- What is Jasper Therapeutics annual shareholders equity year-on-year change?
- What is Jasper Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly shareholders equity year-on-year change?
What is Jasper Therapeutics annual stockholders equity?
The current annual shareholders equity of JSPR is $61.67 M
What is the all time high annual shareholders equity for Jasper Therapeutics?
Jasper Therapeutics all-time high annual stockholders equity is $78.44 M
What is Jasper Therapeutics annual shareholders equity year-on-year change?
Over the past year, JSPR annual stockholders equity has changed by -$16.77 M (-21.37%)
What is Jasper Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of JSPR is $61.67 M
What is the all time high quarterly shareholders equity for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly stockholders equity is $125.20 M
What is Jasper Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, JSPR quarterly stockholders equity has changed by -$22.01 M (-26.30%)